The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation

Long-term changes in the immune system of successfully treated people living with HIV (PLHIV) remain incompletely understood. In this study, we assessed 108 white blood cell (WBC) populations in a cohort of 211 PLHIV on stable antiretroviral therapy and in 56 HIV-uninfected controls using flow cytom...

Full description

Bibliographic Details
Main Authors: Lisa Van de Wijer, Wouter A. van der Heijden, Rob ter Horst, Martin Jaeger, Wim Trypsteen, Sofie Rutsaert, Bram van Cranenbroek, Esther van Rijssen, Irma Joosten, Leo Joosten, Linos Vandekerckhove, Till Schoofs, Jan van Lunzen, Mihai G. Netea, Hans J.P.M. Koenen, André J.A.M. van der Ven, Quirijn de Mast
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
HIV
CMV
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.661990/full
id doaj-e9c41e13fb5e4b64bc9b68de40eb9eb4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Lisa Van de Wijer
Wouter A. van der Heijden
Rob ter Horst
Martin Jaeger
Wim Trypsteen
Sofie Rutsaert
Bram van Cranenbroek
Esther van Rijssen
Irma Joosten
Leo Joosten
Linos Vandekerckhove
Till Schoofs
Jan van Lunzen
Mihai G. Netea
Mihai G. Netea
Hans J.P.M. Koenen
André J.A.M. van der Ven
Quirijn de Mast
spellingShingle Lisa Van de Wijer
Wouter A. van der Heijden
Rob ter Horst
Martin Jaeger
Wim Trypsteen
Sofie Rutsaert
Bram van Cranenbroek
Esther van Rijssen
Irma Joosten
Leo Joosten
Linos Vandekerckhove
Till Schoofs
Jan van Lunzen
Mihai G. Netea
Mihai G. Netea
Hans J.P.M. Koenen
André J.A.M. van der Ven
Quirijn de Mast
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
Frontiers in Immunology
HIV
Th17 & Tregs cells
CD4+/CD8+ lymphocytes
B cell
HIV reservoir
CMV
author_facet Lisa Van de Wijer
Wouter A. van der Heijden
Rob ter Horst
Martin Jaeger
Wim Trypsteen
Sofie Rutsaert
Bram van Cranenbroek
Esther van Rijssen
Irma Joosten
Leo Joosten
Linos Vandekerckhove
Till Schoofs
Jan van Lunzen
Mihai G. Netea
Mihai G. Netea
Hans J.P.M. Koenen
André J.A.M. van der Ven
Quirijn de Mast
author_sort Lisa Van de Wijer
title The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
title_short The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
title_full The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
title_fullStr The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
title_full_unstemmed The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
title_sort architecture of circulating immune cells is dysregulated in people living with hiv on long term antiretroviral treatment and relates with markers of the hiv-1 reservoir, cytomegalovirus, and microbial translocation
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-04-01
description Long-term changes in the immune system of successfully treated people living with HIV (PLHIV) remain incompletely understood. In this study, we assessed 108 white blood cell (WBC) populations in a cohort of 211 PLHIV on stable antiretroviral therapy and in 56 HIV-uninfected controls using flow cytometry. We show that marked differences exist in T cell maturation and differentiation between PLHIV and HIV-uninfected controls: PLHIV had reduced percentages of CD4+ T cells and naïve T cells and increased percentages of CD8+ T cells, effector T cells, and T helper 17 (Th17) cells, together with increased Th17/regulatory T cell (Treg) ratios. PLHIV also exhibited altered B cell maturation with reduced percentages of memory B cells and increased numbers of plasmablasts. Determinants of the T and B cell composition in PLHIV included host factors (age, sex, and smoking), markers of the HIV reservoir, and CMV serostatus. Moreover, higher circulating Th17 percentages were associated with higher plasma concentrations of interleukin (IL) 6, soluble CD14, the gut homing chemokine CCL20, and intestinal fatty acid binding protein (IFABP). The changes in circulating lymphocytes translated into functional changes with reduced interferon (IFN)- γ responses of peripheral blood mononuclear cells to stimulation with Candida albicans and Mycobacterium tuberculosis. In conclusion, this comprehensive analysis confirms the importance of persistent abnormalities in the number and function of circulating immune cells in PLHIV on stable treatment.
topic HIV
Th17 & Tregs cells
CD4+/CD8+ lymphocytes
B cell
HIV reservoir
CMV
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.661990/full
work_keys_str_mv AT lisavandewijer thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT wouteravanderheijden thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT robterhorst thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT martinjaeger thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT wimtrypsteen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT sofierutsaert thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT bramvancranenbroek thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT esthervanrijssen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT irmajoosten thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT leojoosten thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT linosvandekerckhove thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT tillschoofs thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT janvanlunzen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT mihaignetea thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT mihaignetea thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT hansjpmkoenen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT andrejamvanderven thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT quirijndemast thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT lisavandewijer architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT wouteravanderheijden architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT robterhorst architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT martinjaeger architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT wimtrypsteen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT sofierutsaert architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT bramvancranenbroek architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT esthervanrijssen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT irmajoosten architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT leojoosten architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT linosvandekerckhove architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT tillschoofs architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT janvanlunzen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT mihaignetea architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT mihaignetea architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT hansjpmkoenen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT andrejamvanderven architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
AT quirijndemast architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation
_version_ 1721521217584758784
spelling doaj-e9c41e13fb5e4b64bc9b68de40eb9eb42021-04-19T13:50:52ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-04-011210.3389/fimmu.2021.661990661990The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial TranslocationLisa Van de Wijer0Wouter A. van der Heijden1Rob ter Horst2Martin Jaeger3Wim Trypsteen4Sofie Rutsaert5Bram van Cranenbroek6Esther van Rijssen7Irma Joosten8Leo Joosten9Linos Vandekerckhove10Till Schoofs11Jan van Lunzen12Mihai G. Netea13Mihai G. Netea14Hans J.P.M. Koenen15André J.A.M. van der Ven16Quirijn de Mast17Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsHIV Cure Research Center, Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, BelgiumHIV Cure Research Center, Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, BelgiumLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsHIV Cure Research Center, Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, BelgiumViiV Healthcare, Brentford, United KingdomViiV Healthcare, Brentford, United KingdomDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment for Genomics & Immunoregulation, Life and Medical Sciences 12 Institute (LIMES), University of Bonn, Bonn, GermanyLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsLong-term changes in the immune system of successfully treated people living with HIV (PLHIV) remain incompletely understood. In this study, we assessed 108 white blood cell (WBC) populations in a cohort of 211 PLHIV on stable antiretroviral therapy and in 56 HIV-uninfected controls using flow cytometry. We show that marked differences exist in T cell maturation and differentiation between PLHIV and HIV-uninfected controls: PLHIV had reduced percentages of CD4+ T cells and naïve T cells and increased percentages of CD8+ T cells, effector T cells, and T helper 17 (Th17) cells, together with increased Th17/regulatory T cell (Treg) ratios. PLHIV also exhibited altered B cell maturation with reduced percentages of memory B cells and increased numbers of plasmablasts. Determinants of the T and B cell composition in PLHIV included host factors (age, sex, and smoking), markers of the HIV reservoir, and CMV serostatus. Moreover, higher circulating Th17 percentages were associated with higher plasma concentrations of interleukin (IL) 6, soluble CD14, the gut homing chemokine CCL20, and intestinal fatty acid binding protein (IFABP). The changes in circulating lymphocytes translated into functional changes with reduced interferon (IFN)- γ responses of peripheral blood mononuclear cells to stimulation with Candida albicans and Mycobacterium tuberculosis. In conclusion, this comprehensive analysis confirms the importance of persistent abnormalities in the number and function of circulating immune cells in PLHIV on stable treatment.https://www.frontiersin.org/articles/10.3389/fimmu.2021.661990/fullHIVTh17 & Tregs cellsCD4+/CD8+ lymphocytesB cellHIV reservoirCMV